127 related articles for article (PubMed ID: 23236666)
41. [Off-label drug use of the misoprostol in gynecology & obstetrics: From a medico-economics benefit to a potential legal risk].
Decamps-Mini D; Pelofi J; Treisser A
Gynecol Obstet Fertil; 2015 Jun; 43(6):453-8. PubMed ID: 26032707
[TBL] [Abstract][Full Text] [Related]
42. The use of misoprostol in obstetrics and gynaecology.
Elati A; Weeks AD
BJOG; 2009 Oct; 116 Suppl 1():61-9. PubMed ID: 19740175
[TBL] [Abstract][Full Text] [Related]
43. Misoprostol for treatment of incomplete abortion at the regional hospital level: results from Tanzania.
Shwekerela B; Kalumuna R; Kipingili R; Mashaka N; Westheimer E; Clark W; Winikoff B
BJOG; 2007 Nov; 114(11):1363-7. PubMed ID: 17803714
[TBL] [Abstract][Full Text] [Related]
44. [The use of a synthetic analog of prostaglandin E1 for medical treatment of first trimester pregnancy failure].
Houminer A; Kopernic G; Hagay Z
Harefuah; 2009 Jul; 148(7):452-4, 474. PubMed ID: 19848334
[TBL] [Abstract][Full Text] [Related]
45. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.
Shannon C; Wiebe E; Jacot F; Guilbert E; Dunn S; Sheldon WR; Winikoff B
BJOG; 2006 Jun; 113(6):621-8. PubMed ID: 16709204
[TBL] [Abstract][Full Text] [Related]
46. Misoprostol and women's health in Africa.
Okonofua F
Afr J Reprod Health; 2005 Apr; 9(1):7-9, 10-3. PubMed ID: 16104649
[No Abstract] [Full Text] [Related]
47. Success rate of second-trimester termination of pregnancy using misoprostol.
Prachasilpchai N; Russameecharoen K; Borriboonhirunsarn D
J Med Assoc Thai; 2006 Aug; 89(8):1115-9. PubMed ID: 17048418
[TBL] [Abstract][Full Text] [Related]
48. High-dose misoprostol as an alternative therapy after failed medical abortion.
Li YT; Hou GQ; Chen TH; Chu YC; Lin TC; Kuan LC; Lin M; Huang SF; Chen FM; Kuo TC
Taiwan J Obstet Gynecol; 2008 Dec; 47(4):408-11. PubMed ID: 19126506
[TBL] [Abstract][Full Text] [Related]
49. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
Chawdhary R; Rana A; Pradhan N
J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
[TBL] [Abstract][Full Text] [Related]
50. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
[TBL] [Abstract][Full Text] [Related]
51. Off-label indications for mifepristone in gynecology and obstetrics.
Dzuba IG; Grossman D; Schreiber CA
Contraception; 2015 Sep; 92(3):203-5. PubMed ID: 26141817
[No Abstract] [Full Text] [Related]
52. [Use of Misoprostol for pregnancy termination in the second trimester].
Stambolov B; Ninkova E; Vladova D; Vasilev H
Akush Ginekol (Sofiia); 2002; 41 Suppl 2():24-5. PubMed ID: 19705687
[No Abstract] [Full Text] [Related]
53. [Medical abortion using methotrexate and misoprostol. Efficacy and tolerability].
Iamakov K; Pekhlivanov B; Amaliev I
Akush Ginekol (Sofiia); 2005; 44(3):16-8. PubMed ID: 16028385
[TBL] [Abstract][Full Text] [Related]
54. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.
Gemzell-Danielsson K; Lalitkumar S
Reprod Health Matters; 2008 May; 16(31 Suppl):162-72. PubMed ID: 18772097
[TBL] [Abstract][Full Text] [Related]
55. Experience with misoprostol in the management of missed abortion in the second trimester.
Menakaya U; Otoide V; Omo Aghoja L; Odunsi K; Okonofua F
J Obstet Gynaecol; 2005 Aug; 25(6):583-5. PubMed ID: 16234145
[TBL] [Abstract][Full Text] [Related]
56. Experience with intravaginal misoprostol in the management of intra-uterine fetal death.
Fawole AO; Adekunle AO; Sotiloye OS; Arowojolu AO; Otolorin EO
Afr J Med Med Sci; 2004 Jun; 33(2):105-8. PubMed ID: 15565925
[TBL] [Abstract][Full Text] [Related]
57. Abortion induced with methotrexate and misoprostol.
Wiebe ER
CMAJ; 1996 Jan; 154(2):165-70. PubMed ID: 8548705
[TBL] [Abstract][Full Text] [Related]
58. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.
Goh SE; Thong KJ
Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037
[TBL] [Abstract][Full Text] [Related]
59. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
[TBL] [Abstract][Full Text] [Related]
60. Misoprostol and the debate over off-label drug use.
Weeks AD; Fiala C; Safar P
BJOG; 2005 Mar; 112(3):269-72. PubMed ID: 15713138
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
